Back to Search Start Over

Blueprint of human thymopoiesis reveals molecular mechanisms of stage-specific TCR enhancer activation

Authors :
Joost H.A. Martens
Guillaume Hypolite
Guillaume Andrieu
Charlotte Smith
Melania Tesio
Denis Puthier
Eva M. Janssen-Megens
Guillaume Charbonnier
Hendrik G. Stunnenberg
Ivo Gut
Salvatore Spicuglia
Marta Gut
Mohamed Belhocine
Nicolas Boissel
Eve-Lyne Mathieu
Vahid Asnafi
Elizabeth Macintyre
Arnaud Petit
Aurore Touzart
Agata Cieslak
Institut Necker Enfants-Malades (INEM - UM 111 (UMR 8253 / U1151))
Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP)
Theories and Approaches of Genomic Complexity (TAGC)
Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Radboud university [Nijmegen]
Universitat Pompeu Fabra [Barcelona] (UPF)
Hopital Saint-Louis [AP-HP] (AP-HP)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
CHU Trousseau [APHP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Plan Cancer2015 (C15076AS), PlBio-INCA, and Equipe Labelis ́ee Ligue contrele Cancer
ANR-11-IDEX-0001,Amidex,INITIATIVE D'EXCELLENCE AIX MARSEILLE UNIVERSITE(2011)
European Project: 282510,EC:FP7:HEALTH,FP7-HEALTH-2011-single-stage,BLUEPRINT(2011)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité)
Radboud University [Nijmegen]
Source :
The Journal of Experimental Medicine, Journal of Experimental Medicine, Journal of Experimental Medicine, Rockefeller University Press, 2020, 217 (9), ⟨10.1084/jem.20192360⟩, Journal of Experimental Medicine, 2020, 217 (9), ⟨10.1084/jem.20192360⟩, Journal of Experimental Medicine, 217, 9, pp. 1-28, Journal of Experimental Medicine, 217, 1-28
Publication Year :
2020
Publisher :
Rockefeller University Press, 2020.

Abstract

This manuscript presents a comprehensive epigenomic analysis of human thymocyte development and provides new molecular insights into the mechanism by which the TCRA enhancer is activated during thymic maturation by developmentally programmed repression of HOXA factors.<br />Cell differentiation is accompanied by epigenetic changes leading to precise lineage definition and cell identity. Here we present a comprehensive resource of epigenomic data of human T cell precursors along with an integrative analysis of other hematopoietic populations. Although T cell commitment is accompanied by large scale epigenetic changes, we observed that the majority of distal regulatory elements are constitutively unmethylated throughout T cell differentiation, irrespective of their activation status. Among these, the TCRA gene enhancer (Eα) is in an open and unmethylated chromatin structure well before activation. Integrative analyses revealed that the HOXA5-9 transcription factors repress the Eα enhancer at early stages of T cell differentiation, while their decommission is required for TCRA locus activation and enforced αβ T lineage differentiation. Remarkably, the HOXA-mediated repression of Eα is paralleled by the ectopic expression of homeodomain-related oncogenes in T cell acute lymphoblastic leukemia. These results highlight an analogous enhancer repression mechanism at play in normal and cancer conditions, but imposing distinct developmental constraints.<br />Graphical Abstract

Details

Language :
English
ISSN :
00221007 and 15409538
Database :
OpenAIRE
Journal :
The Journal of Experimental Medicine, Journal of Experimental Medicine, Journal of Experimental Medicine, Rockefeller University Press, 2020, 217 (9), ⟨10.1084/jem.20192360⟩, Journal of Experimental Medicine, 2020, 217 (9), ⟨10.1084/jem.20192360⟩, Journal of Experimental Medicine, 217, 9, pp. 1-28, Journal of Experimental Medicine, 217, 1-28
Accession number :
edsair.doi.dedup.....de66f73e71e66697e93213ace5c73bfa
Full Text :
https://doi.org/10.1084/jem.20192360⟩